202 related articles for article (PubMed ID: 25080123)
1. Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.
Hagemann UB; Gunnarsson L; Géraudie S; Scheffler U; Griep RA; Reiersen H; Duncan AR; Kiprijanov SM
PLoS One; 2014; 9(7):e103776. PubMed ID: 25080123
[TBL] [Abstract][Full Text] [Related]
2. Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells.
Chang DK; Sui J; Geng S; Muvaffak A; Bai M; Fuhlbrigge RC; Lo A; Yammanuru A; Hubbard L; Sheehan J; Campbell JJ; Zhu Q; Kupper TS; Marasco WA
Mol Cancer Ther; 2012 Nov; 11(11):2451-61. PubMed ID: 22869555
[TBL] [Abstract][Full Text] [Related]
3. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
[TBL] [Abstract][Full Text] [Related]
4. CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.
Maeda S; Murakami K; Inoue A; Yonezawa T; Matsuki N
Cancer Immunol Res; 2019 Jul; 7(7):1175-1187. PubMed ID: 31160277
[TBL] [Abstract][Full Text] [Related]
5. Tumors establish resistance to immunotherapy by regulating T
Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
[TBL] [Abstract][Full Text] [Related]
6. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
[TBL] [Abstract][Full Text] [Related]
7. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
Di Stasi A; De Angelis B; Rooney CM; Zhang L; Mahendravada A; Foster AE; Heslop HE; Brenner MK; Dotti G; Savoldo B
Blood; 2009 Jun; 113(25):6392-402. PubMed ID: 19377047
[TBL] [Abstract][Full Text] [Related]
8. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
[TBL] [Abstract][Full Text] [Related]
9. Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist.
Sato T; Iwase M; Miyama M; Komai M; Ohshima E; Asai A; Yano H; Miki I
Pharmacology; 2013; 91(5-6):305-13. PubMed ID: 23751403
[TBL] [Abstract][Full Text] [Related]
10. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
[TBL] [Abstract][Full Text] [Related]
11. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
[TBL] [Abstract][Full Text] [Related]
12. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
[TBL] [Abstract][Full Text] [Related]
13. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer.
Berlato C; Khan MN; Schioppa T; Thompson R; Maniati E; Montfort A; Jangani M; Canosa M; Kulbe H; Hagemann UB; Duncan AR; Fletcher L; Wilkinson RW; Powles T; Quezada SA; Balkwill FR
J Clin Invest; 2017 Mar; 127(3):801-813. PubMed ID: 28134623
[TBL] [Abstract][Full Text] [Related]
14. [Anti-CCR4 mAb and regulatory T cells].
Kurose K; Ohue Y; Oka M
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773
[TBL] [Abstract][Full Text] [Related]
15. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
[TBL] [Abstract][Full Text] [Related]
16. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma.
Tian L; Li W; Wang J; Zhang Y; Zheng Y; Qi H; Guo X; Zhang Y; Ma D; Shen H; Wang Y
Allergy; 2011 Feb; 66(2):287-97. PubMed ID: 21208220
[TBL] [Abstract][Full Text] [Related]
17. Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
Han T; Abdel-Motal UM; Chang DK; Sui J; Muvaffak A; Campbell J; Zhu Q; Kupper TS; Marasco WA
PLoS One; 2012; 7(9):e44455. PubMed ID: 22973452
[TBL] [Abstract][Full Text] [Related]
18. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.
Imai T; Baba M; Nishimura M; Kakizaki M; Takagi S; Yoshie O
J Biol Chem; 1997 Jun; 272(23):15036-42. PubMed ID: 9169480
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput chemotaxis detection method for CCR4
Magnotti EL; Chan LL; Zhu Q; Marasco WA
J Immunol Methods; 2020 Apr; 479():112747. PubMed ID: 31958449
[TBL] [Abstract][Full Text] [Related]
20. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
